NASDAQ: KZIA
Kazia Therapeutics Ltd Stock Ownership - Who owns Kazia Therapeutics?

Insider buying vs selling

Have Kazia Therapeutics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when KZIA insiders and whales buy or sell their stock.

KZIA Shareholders

What type of owners hold Kazia Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Josiah T. Austin33.42%22,247,131$206.90MInsider
Barclays PLC0.18%120,000$1.12MInstitution
Ubs Group Ag0.04%26,285$244.45kInstitution
Mai Capital Management0.01%3,854$35.84kInstitution
Rhumbline Advisers0.00%1,911$17.77kInstitution
Gamma Investing LLC0.00%1,327$12.34kInstitution
Arax Advisory Partners0.00%1,000$9.30kInstitution
Osaic Holdings Inc0.00%50$465.00Institution
Simplex Trading LLC0.00%5$46.50Institution
Wells Fargo Company0.00%4$37.20Institution

1 of 2

KZIA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KZIA0.23%33.42%
APM1.68%37.21%
SNGX0.14%99.86%
KTTA0.77%99.23%Net SellingNet Selling
INTS14.07%10.91%

Kazia Therapeutics Stock Ownership FAQ

Who owns Kazia Therapeutics?

Kazia Therapeutics (NASDAQ: KZIA) is owned by 0.23% institutional shareholders, 33.42% Kazia Therapeutics insiders, and 66.35% retail investors. Josiah T. Austin is the largest individual Kazia Therapeutics shareholder, owning 22.25M shares representing 33.42% of the company. Josiah T. Austin's Kazia Therapeutics shares are currently valued at $206.90M.

If you're new to stock investing, here's how to buy Kazia Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.